These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2578128)

  • 21. Immunochemical characterization of antigenic domains on human interferon-beta: spatially distinct epitopes are associated with both antiviral and antiproliferative activities.
    Redlich PN; Grossberg SE
    Eur J Immunol; 1990 Sep; 20(9):1933-9. PubMed ID: 1698636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human IFN gamma receptor cytoplasmic domain: expression and interaction with HuIFN gamma.
    Green MM; Larkin J; Subramaniam PS; Szente BE; Johnson HM
    Biochem Biophys Res Commun; 1998 Feb; 243(1):170-6. PubMed ID: 9473500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta.
    Oleszak E; Stewart WE
    J Interferon Res; 1985; 5(2):361-71. PubMed ID: 2989390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity.
    Byrne GI; Lehmann LK; Kirschbaum JG; Borden EC; Lee CM; Brown RR
    J Interferon Res; 1986 Aug; 6(4):389-96. PubMed ID: 3095441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of E. coli-derived recombinant human interferon-beta as compared with fibroblast human interferon-beta.
    Utsumi J; Yamazaki S; Hosoi K; Kimura S; Hanada K; Shimazu T; Shimizu H
    J Biochem; 1987 May; 101(5):1199-208. PubMed ID: 3308862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of suramin on human interferon alpha binding to cell receptors.
    Kandefer-Szerszeń M; Ruuth K; Lundgren E
    Arch Immunol Ther Exp (Warsz); 1997; 45(1):93-9. PubMed ID: 9090447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the steady state binding, internalization, and degradation of human interferon-alpha2.
    Zoon KC; Zur Nedden D; Hu R; Arnheiter H
    J Biol Chem; 1986 Apr; 261(11):4993-6. PubMed ID: 2937783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
    J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
    Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro biological activities of Escherichia coli-derived bovine interferons-alpha, -beta, and -gamma.
    Czarniecki CW; Hamilton EB; Fennie CW; Wolf RL
    J Interferon Res; 1986 Feb; 6(1):29-37. PubMed ID: 2939154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of bacteria-produced human alpha, beta, and gamma interferons on in vitro immune functions.
    Shalaby MR; Weck PK; Rinderknecht E; Harkins RN; Frane JW; Ross MJ
    Cell Immunol; 1984 Apr; 84(2):380-92. PubMed ID: 6231112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon system of human cornea cells: interferon production, characterization, and development of antiviral state.
    Thacore HR; Mount DT; Chadha KC
    J Interferon Res; 1982; 2(3):401-8. PubMed ID: 6182255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness of human cells trisomic for chromosome 21 to the antiviral action of human immune interferon.
    De Ley M; Billiau A
    Antiviral Res; 1982 May; 2(1-2):97-102. PubMed ID: 6179471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data.
    Merlin G; Falcoff E; Aguet M
    J Gen Virol; 1985 May; 66 ( Pt 5)():1149-52. PubMed ID: 3158718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of interferon synthesis in lymphoblastoid cells.
    Raj NB; Kellum M; Kelley KA; Antrobus S; Pitha PM
    J Interferon Res; 1985; 5(3):493-510. PubMed ID: 2997339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of specific functional receptors for HuIFN-alpha on a human megakaryocytic cell line (Dami): expression related to differentiation.
    Martyré MC; Wietzerbin J
    Br J Haematol; 1994 Feb; 86(2):244-52. PubMed ID: 8199013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
    Yoshida R; Murray HW; Nathan CF
    J Exp Med; 1988 Mar; 167(3):1171-85. PubMed ID: 2965208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of 125I-labelled human alpha interferon to human lymphoid cells.
    Mogensen KE; Bandu MT; Vignaux F; Aguet M; Gressner I
    Int J Cancer; 1981 Nov; 28(5):575-82. PubMed ID: 6171531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
    Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
    Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.